OncoMatch/Clinical Trials/NCT05943119
Phase II Study of Intensity Modulated Radiotherapy in Dose Painting for Sinus Carcinomas After Endoscopic Surgery
Is NCT05943119 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies non-drug interventions for tumor, solid.
The patient is randomized to one of the following groups: * Experimental group: Radiotherapy in painting dose on histoscannographic mapping * Control group: standard pan-sinus radiotherapy
Check if I qualifyExtracted eligibility criteria
Prior therapy
Must have received: endoscopic sinonasal surgery
Cannot have received: neoadjuvant chemotherapy
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify